-
Je něco špatně v tomto záznamu ?
Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI
CP. Spielvogel, J. Ning, K. Kluge, D. Haberl, G. Wasinger, J. Yu, H. Einspieler, L. Papp, B. Grubmüller, SF. Shariat, PAT. Baltzer, P. Clauser, M. Hartenbach, L. Kenner, M. Hacker, AR. Haug, S. Rasul
Status neindexováno Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2012
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
ProQuest Central
od 2012-08-01
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2012-01-01
Nursing & Allied Health Database (ProQuest)
od 2012-08-01
Health & Medicine (ProQuest)
od 2012-08-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
Springer Journals Complete - Open Access
od 2010-01-01
Springer Nature OA/Free Journals
od 2010-01-01
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: Radical prostatectomy (RP) is a common intervention in patients with localized prostate cancer (PCa), with nerve-sparing RP recommended to reduce adverse effects on patient quality of life. Accurate pre-operative detection of extraprostatic extension (EPE) remains challenging, often leading to the application of suboptimal treatment. The aim of this study was to enhance pre-operative EPE detection through multimodal data integration using explainable machine learning (ML). METHODS: Patients with newly diagnosed PCa who underwent [68Ga]Ga-PSMA-11 PET/MRI and subsequent RP were recruited retrospectively from two time ranges for training, cross-validation, and independent validation. The presence of EPE was measured from post-surgical histopathology and predicted using ML and pre-operative parameters, including PET/MRI-derived features, blood-based markers, histology-derived parameters, and demographic parameters. ML models were subsequently compared with conventional PET/MRI-based image readings. RESULTS: The study involved 107 patients, 59 (55%) of whom were affected by EPE according to postoperative findings for the initial training and cross-validation. The ML models demonstrated superior diagnostic performance over conventional PET/MRI image readings, with the explainable boosting machine model achieving an AUC of 0.88 (95% CI 0.87-0.89) during cross-validation and an AUC of 0.88 (95% CI 0.75-0.97) during independent validation. The ML approach integrating invasive features demonstrated better predictive capabilities for EPE compared to visual clinical read-outs (Cross-validation AUC 0.88 versus 0.71, p = 0.02). CONCLUSION: ML based on routinely acquired clinical data can significantly improve the pre-operative detection of EPE in PCa patients, potentially enabling more accurate clinical staging and decision-making, thereby improving patient outcomes. CRITICAL RELEVANCE STATEMENT: This study demonstrates that integrating multimodal data with machine learning significantly improves the pre-operative detection of extraprostatic extension in prostate cancer patients, outperforming conventional imaging methods and potentially leading to more accurate clinical staging and better treatment decisions. KEY POINTS: Extraprostatic extension is an important indicator guiding treatment approaches. Current assessment of extraprostatic extension is difficult and lacks accuracy. Machine learning improves detection of extraprostatic extension using PSMA-PET/MRI and histopathology.
Center for Biomarker Research in Medicine Graz Austria
Center for Medical Physics and Biomedical Engineering Medical University of Vienna Vienna Austria
Christian Doppler Laboratory for Applied Metabolomics Vienna Austria
Department of Pathology Medical University of Vienna Vienna Austria
Department of Urology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Urology and Andrology University Hospital Krems Krems Austria
Department of Urology Medical University of Vienna Vienna Austria
Department of Urology University of Texas Southwestern Medical Center Dallas USA
Department of Urology Weill Cornell Medical College New York USA
Division of Urology Department of Special Surgery The University of Jordan Amman Jordan
Karl Landsteiner Institute of Urology and Andrology Vienna Austria
Karl Landsteiner University of Health Sciences Krems Austria
Unit for Pathology of Laboratory Animals University of Veterinary Medicine Vienna Vienna Austria
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25001956
- 003
- CZ-PrNML
- 005
- 20250123102001.0
- 007
- ta
- 008
- 250117s2024 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13244-024-01876-5 $2 doi
- 035 __
- $a (PubMed)39666257
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Spielvogel, Clemens P $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
- 245 10
- $a Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI / $c CP. Spielvogel, J. Ning, K. Kluge, D. Haberl, G. Wasinger, J. Yu, H. Einspieler, L. Papp, B. Grubmüller, SF. Shariat, PAT. Baltzer, P. Clauser, M. Hartenbach, L. Kenner, M. Hacker, AR. Haug, S. Rasul
- 520 9_
- $a OBJECTIVES: Radical prostatectomy (RP) is a common intervention in patients with localized prostate cancer (PCa), with nerve-sparing RP recommended to reduce adverse effects on patient quality of life. Accurate pre-operative detection of extraprostatic extension (EPE) remains challenging, often leading to the application of suboptimal treatment. The aim of this study was to enhance pre-operative EPE detection through multimodal data integration using explainable machine learning (ML). METHODS: Patients with newly diagnosed PCa who underwent [68Ga]Ga-PSMA-11 PET/MRI and subsequent RP were recruited retrospectively from two time ranges for training, cross-validation, and independent validation. The presence of EPE was measured from post-surgical histopathology and predicted using ML and pre-operative parameters, including PET/MRI-derived features, blood-based markers, histology-derived parameters, and demographic parameters. ML models were subsequently compared with conventional PET/MRI-based image readings. RESULTS: The study involved 107 patients, 59 (55%) of whom were affected by EPE according to postoperative findings for the initial training and cross-validation. The ML models demonstrated superior diagnostic performance over conventional PET/MRI image readings, with the explainable boosting machine model achieving an AUC of 0.88 (95% CI 0.87-0.89) during cross-validation and an AUC of 0.88 (95% CI 0.75-0.97) during independent validation. The ML approach integrating invasive features demonstrated better predictive capabilities for EPE compared to visual clinical read-outs (Cross-validation AUC 0.88 versus 0.71, p = 0.02). CONCLUSION: ML based on routinely acquired clinical data can significantly improve the pre-operative detection of EPE in PCa patients, potentially enabling more accurate clinical staging and decision-making, thereby improving patient outcomes. CRITICAL RELEVANCE STATEMENT: This study demonstrates that integrating multimodal data with machine learning significantly improves the pre-operative detection of extraprostatic extension in prostate cancer patients, outperforming conventional imaging methods and potentially leading to more accurate clinical staging and better treatment decisions. KEY POINTS: Extraprostatic extension is an important indicator guiding treatment approaches. Current assessment of extraprostatic extension is difficult and lacks accuracy. Machine learning improves detection of extraprostatic extension using PSMA-PET/MRI and histopathology.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ning, Jing $u Christian Doppler Laboratory for Applied Metabolomics, Vienna, Austria $u Department of Pathology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Kluge, Kilian $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria $u Christian Doppler Laboratory for Applied Metabolomics, Vienna, Austria
- 700 1_
- $a Haberl, David $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Wasinger, Gabriel $u Department of Pathology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Yu, Josef $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Einspieler, Holger $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Papp, Laszlo $u Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Grubmüller, Bernhard $u Department of Urology and Andrology, University Hospital Krems, Krems, Austria $u Karl Landsteiner University of Health Sciences, Krems, Austria $u Department of Urology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Shariat, Shahrokh F $u Department of Urology, Medical University of Vienna, Vienna, Austria $u Department of Urology, University of Texas Southwestern Medical Center, Dallas, USA $u Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Urology, Weill Cornell Medical College, New York, USA $u Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria
- 700 1_
- $a Baltzer, Pascal A T $u Department of Biomedical Imaging and Image-Guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Clauser, Paola $u Department of Biomedical Imaging and Image-Guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Hartenbach, Markus $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Kenner, Lukas $u Christian Doppler Laboratory for Applied Metabolomics, Vienna, Austria $u Department of Pathology, Medical University of Vienna, Vienna, Austria $u Center for Biomarker Research in Medicine, Graz, Austria $u Unit for Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, Vienna, Austria
- 700 1_
- $a Hacker, Marcus $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Haug, Alexander R $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria $u Christian Doppler Laboratory for Applied Metabolomics, Vienna, Austria
- 700 1_
- $a Rasul, Sazan $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria. sazan.rasul@meduniwien.ac.at $1 https://orcid.org/0000000328983232
- 773 0_
- $w MED00181719 $t Insights into imaging $x 1869-4101 $g Roč. 15, č. 1 (2024), s. 299
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39666257 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250117 $b ABA008
- 991 __
- $a 20250123101955 $b ABA008
- 999 __
- $a ok $b bmc $g 2254429 $s 1237959
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 15 $c 1 $d 299 $e 20241212 $i 1869-4101 $m Insights into imaging $n Insights Imaging $x MED00181719
- LZP __
- $a Pubmed-20250117